| # | Title | Journal | Year | Citations |
|---|
| 1 | Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan | Emerging Microbes and Infections | 2020 | 2,389 |
| 2 | Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes | Emerging Microbes and Infections | 2020 | 1,471 |
| 3 | Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody | Emerging Microbes and Infections | 2020 | 1,086 |
| 4 | Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients | Emerging Microbes and Infections | 2020 | 994 |
| 5 | Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors | Emerging Microbes and Infections | 2020 | 877 |
| 6 | Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia | Emerging Microbes and Infections | 2020 | 684 |
| 7 | Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2 | Emerging Microbes and Infections | 2020 | 638 |
| 8 | Laboratory diagnosis of emerging human coronavirus infections – the state of the art | Emerging Microbes and Infections | 2020 | 612 |
| 9 | Streptococcus suis , an important pig pathogen and emerging zoonotic agent—an update on the worldwide distribution based on serotyping and sequence typing | Emerging Microbes and Infections | 2014 | 515 |
| 10 | Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension | Emerging Microbes and Infections | 2020 | 515 |
| 11 | Emerging COVID-19 coronavirus: glycan shield and structure prediction of spike glycoprotein and its interaction with human CD26 | Emerging Microbes and Infections | 2020 | 508 |
| 12 | RNA based mNGS approach identifies a novel human coronavirus from two individual pneumonia cases in 2019 Wuhan outbreak | Emerging Microbes and Infections | 2020 | 471 |
| 13 | IL-17 cytokines in immunity and inflammation | Emerging Microbes and Infections | 2013 | 446 |
| 14 | SARS-CoV-2 nsp13, nsp14, nsp15 and orf6 function as potent interferon antagonists | Emerging Microbes and Infections | 2020 | 439 |
| 15 | Kinetics of SARS-CoV-2 specific IgM and IgG responses in COVID-19 patients | Emerging Microbes and Infections | 2020 | 414 |
| 16 | Emergence of a novel mobile colistin resistance gene, mcr-8, in NDM-producing Klebsiella pneumoniae | Emerging Microbes and Infections | 2018 | 404 |
| 17 | Colistin and its role in the Era of antibiotic resistance: an extended review (2000–2019) | Emerging Microbes and Infections | 2020 | 349 |
| 18 | Identification of novel mobile colistin resistance gene mcr-10 | Emerging Microbes and Infections | 2020 | 346 |
| 19 | Detectable 2019-nCoV viral RNA in blood is a strong indicator for the further clinical severity | Emerging Microbes and Infections | 2020 | 339 |
| 20 | ddPCR: a more accurate tool for SARS-CoV-2 detection in low viral load specimens | Emerging Microbes and Infections | 2020 | 333 |
| 21 | COVID-19 pandemic – an African perspective | Emerging Microbes and Infections | 2020 | 322 |
| 22 | The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron | Emerging Microbes and Infections | 2022 | 320 |
| 23 | A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses | Emerging Microbes and Infections | 2020 | 310 |
| 24 | SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells | Emerging Microbes and Infections | 2022 | 308 |
| 25 | Clinical observation and management of COVID-19 patients | Emerging Microbes and Infections | 2020 | 306 |
| 26 | Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost | Emerging Microbes and Infections | 2022 | 303 |
| 27 | Propionibacterium acnes induces intervertebral disc degeneration by promoting nucleus pulposus cell apoptosis via the TLR2/JNK/mitochondrial-mediated pathway | Emerging Microbes and Infections | 2018 | 291 |
| 28 | Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient | Emerging Microbes and Infections | 2020 | 276 |
| 29 | The different clinical characteristics of corona virus disease cases between children and their families in China – the character of children with COVID-19 | Emerging Microbes and Infections | 2020 | 270 |
| 30 | Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction | Emerging Microbes and Infections | 2020 | 270 |
| 31 | An emerging coronavirus causing pneumonia outbreak in Wuhan, China: calling for developing therapeutic and prophylactic strategies | Emerging Microbes and Infections | 2020 | 268 |
| 32 | Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2 | Emerging Microbes and Infections | 2020 | 267 |
| 33 | An update on the human and animal enteric pathogen Clostridium perfringens | Emerging Microbes and Infections | 2018 | 262 |
| 34 | A serological survey of SARS-CoV-2 in cat in Wuhan | Emerging Microbes and Infections | 2020 | 240 |
| 35 | Different longitudinal patterns of nucleic acid and serology testing results based on disease severity of COVID-19 patients | Emerging Microbes and Infections | 2020 | 239 |
| 36 | Pathogen–host–environment interplay and disease emergence | Emerging Microbes and Infections | 2013 | 238 |
| 37 | Replication and virulence in pigs of the first African swine fever virus isolated in China | Emerging Microbes and Infections | 2019 | 235 |
| 38 | Genomic characterization and infectivity of a novel SARS-like coronavirus in Chinese bats | Emerging Microbes and Infections | 2018 | 230 |
| 39 | Rapid inactivation of SARS-CoV-2 with deep-UV LED irradiation | Emerging Microbes and Infections | 2020 | 227 |
| 40 | Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells | Emerging Microbes and Infections | 2020 | 221 |
| 41 | SARS-CoV-2 infection, disease and transmission in domestic cats | Emerging Microbes and Infections | 2020 | 215 |
| 42 | Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case–control real-world study | Emerging Microbes and Infections | 2021 | 206 |
| 43 | Lessons learned 1 year after SARS-CoV-2 emergence leading to COVID-19 pandemic | Emerging Microbes and Infections | 2021 | 202 |
| 44 | Talaromyces (Penicillium) marneffei infection in non-HIV-infected patients | Emerging Microbes and Infections | 2016 | 201 |
| 45 | Identification of 53 compounds that block Ebola virus-like particle entry via a repurposing screen of approved drugs | Emerging Microbes and Infections | 2014 | 200 |
| 46 | Defining the Syrian hamster as a highly susceptible preclinical model for SARS-CoV-2 infection | Emerging Microbes and Infections | 2020 | 193 |
| 47 | Rapidly produced SAM® vaccine against H7N9 influenza is immunogenic in mice | Emerging Microbes and Infections | 2013 | 189 |
| 48 | Persisters, persistent infections and the Yin–Yang model | Emerging Microbes and Infections | 2014 | 180 |
| 49 | Blockade of the C5a–C5aR axis alleviates lung damage in hDPP4-transgenic mice infected with MERS-CoV | Emerging Microbes and Infections | 2018 | 180 |
| 50 | SARS-CoV-2 proteases PLpro and 3CLpro cleave IRF3 and critical modulators of inflammatory pathways (NLRP12 and TAB1): implications for disease presentation across species | Emerging Microbes and Infections | 2021 | 178 |
